SH003 overcomes drug resistance and immune checkpoints by inhibiting JAK-STAT3 signaling in MCF7/ADR cells
Background: Breast cancer has the most commonly diagnosed malignancy cancer worldwide in women and has a high mortality. Various anticancer drugs to treat breast cancer have been developed and tested but have failed because of drug resistance. Objectives: The efficacy of SH003 against doxorubicin-re...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-11-01
|
| Series: | Phytomedicine Plus |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667031321000932 |